Effect of rosuvastatin on triglyceride levels in Mexican hypertriglyceridemic patients

Study identifier:DM-CRESTOR-0002

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A double-blind, double dummy, phase IV, randomized, multicenter, parallel group, placebo controlled trial to evaluate the effect of rosuvastatin on triglycerides levels in Mexican hypertriglyceridemic patients

Medical condition

Hypertriglyceridemia

Phase

Phase 4

Healthy volunteers

No

Study drug

rosuvastatin

Sex

All

Actual Enrollment

334

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 01 Jan 2007
Primary Completion Date: 01 Feb 2009
Study Completion Date: 01 Feb 2009

Study design

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2010 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria